skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Uric Acid as a Cause of the Metabolic Syndrome

Uric Acid in Chronic Kidney Disease, 2018, Vol.192, p.88-102 [Peer Reviewed Journal]

2018 S. Karger AG, Basel ;ISSN: 0302-5144 ;ISBN: 3318062502 ;ISBN: 9783318062502 ;EISSN: 1662-2782 ;EISBN: 3318062510 ;EISBN: 9783318062519 ;DOI: 10.1159/000484283 ;OCLC: 1021808911 ;PMID: 29393133

Full text available

Citations Cited by
  • Title:
    Uric Acid as a Cause of the Metabolic Syndrome
  • Author: King, Christopher ; Lanaspa, Miguel A ; Jensen, Thomas ; Tolan, Dean R ; Sánchez-Lozada, L. Gabriela ; Johnson, Richard J
  • Treviño-Becerra, A ; Iseki, K
  • Subjects: Chapter ; Epidemiology & medical statistics ; Pathology ; Renal medicine
  • Is Part Of: Uric Acid in Chronic Kidney Disease, 2018, Vol.192, p.88-102
  • Description: Hyperuricemia is common in subjects with obesity, metabolic syndrome, and type 2 diabetes. For many years, hyperuricemia was attributed to the effects of insulin resistance to reduce urinary excretion of uric acid, and it was believed that uric acid may not have any causal role in the metabolic syndrome. However, in recent years, hyperuricemia has been found to independently predict the development of diabetes. Experimental studies have also shown that hyperuricemia may mediate insulin resistance, fatty liver, and dyslipidemia in both fructose-dependent and fructose-independent models of metabolic syndrome. The mechanism for uric acid-induced insulin resistance appears to be mediated by the development of mitochondrial oxidative stress and impairment of insulin-dependent stimulation of nitric oxide in endothelial cells. Pilot studies in humans have reported a potential benefit of lowering serum uric acid on insulin resistance. Large clinical trials are recommended. If uric acid is shown to be a mediator of incident type 2 diabetes in humans, then lowering serum uric acid would represent a simple and inexpensive way to help prevent the development of diabetes and to slow the epidemic.
  • Publisher: Basel, Switzerland: S. Karger AG
  • Language: English
  • Identifier: ISSN: 0302-5144
    ISBN: 3318062502
    ISBN: 9783318062502
    EISSN: 1662-2782
    EISBN: 3318062510
    EISBN: 9783318062519
    DOI: 10.1159/000484283
    OCLC: 1021808911
    PMID: 29393133
  • Source: Alma/SFX Local Collection
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait